BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10986550)

  • 1. Growth hormone secretion in children and adolescents at high risk for major depressive disorder.
    Birmaher B; Dahl RE; Williamson DE; Perel JM; Brent DA; Axelson DA; Kaufman J; Dorn LD; Stull S; Rao U; Ryan ND
    Arch Gen Psychiatry; 2000 Sep; 57(9):867-72. PubMed ID: 10986550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low growth hormone response to growth hormone-releasing hormone in child depression.
    Dahl RE; Birmaher B; Williamson DE; Dorn L; Perel J; Kaufman J; Brent DA; Axelson DA; Ryan ND
    Biol Psychiatry; 2000 Nov; 48(10):981-8. PubMed ID: 11082472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nocturnal growth hormone secretion studies in adolescents with or without major depression re-examined: integration of adult clinical follow-up data.
    Coplan JD; Wolk SI; Goetz RR; Ryan ND; Dahl RE; Mann JJ; Weissman MM
    Biol Psychiatry; 2000 Apr; 47(7):594-604. PubMed ID: 10745051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulatory tests of growth hormone secretion in prepubertal major depression: depressed versus normal children.
    Ryan ND; Dahl RE; Birmaher B; Williamson DE; Iyengar S; Nelson B; Puig-Antich J; Perel JM
    J Am Acad Child Adolesc Psychiatry; 1994; 33(6):824-33. PubMed ID: 8083139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
    Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of growth hormone secretion after testosterone treatment in boys with constitutional delay of growth and adolescence: evidence against an increase in hypothalamic secretion of growth hormone-releasing hormone.
    Racine MS; Symons KV; Foster CM; Barkan AL
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3326-31. PubMed ID: 15240610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
    Cordido F; Fernandez T; Martinez T; Peñalva A; Peinó R; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4350-4. PubMed ID: 9851776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating non-22 kDa growth hormone isoforms after a repeated GHRH stimulus in normal subjects.
    Coya R; Algorta J; Boguszewski CL; Vela A; Carlsson LM; Aniel-Quiroga A; Busturia MA; Martul P
    Growth Horm IGF Res; 2005 Apr; 15(2):123-9. PubMed ID: 15809015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone (GH) response to GH-releasing hormone in short children: lack of correlation with endogenous nocturnal GH secretion.
    Seminara S; Filpo A; Piccinini P; La Cauza F; Cappa M; Faedda A; Loche S
    J Endocrinol Invest; 1997 Mar; 20(3):118-21. PubMed ID: 9186816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of overnight constant infusion of human growth hormone (GH)-releasing hormone-(1-44) on 24-hour GH secretion in children with partial GH deficiency.
    Rochiccioli PE; Tauber MT; Uboldi F; Coude FX; Morre M
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1100-5. PubMed ID: 3093519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH2 and in combination in older men and women with decreased growth hormone secretion.
    Bowers CY; Granda-Ayala R
    Endocrine; 2001 Feb; 14(1):79-86. PubMed ID: 11322505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
    Ghigo E; Imperiale E; Boffano GM; Mazza E; Bellone J; Arvat E; Procopio M; Goffi S; Barreca A; Chiabotto P
    J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nocturnal continuous infusion of growth hormone (GH)-releasing hormone results in a dose-dependent accentuation of episodic GH secretion in normal men.
    Sassolas G; Garry J; Cohen R; Bastuji H; Vermeulen E; Cabrera P; Roussel B; Jouvet M
    J Clin Endocrinol Metab; 1986 Oct; 63(4):1016-22. PubMed ID: 3091627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated escape from GH autonegative feedback in midpuberty in males: evidence for time-delimited GH-induced somatostatinergic outflow in adolescent boys.
    Richmond E; Rogol AD; Basdemir D; Veldhuis OL; Clarke W; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3837-44. PubMed ID: 12161519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsatile growth hormone secretion in patients with acromegaly and normal men: the effects of growth hormone-releasing hormone infusion.
    Gelato MC; Oldfield E; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1990 Sep; 71(3):585-90. PubMed ID: 2118536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Action of growth hormone releasing hormone (GHRH) on sleep EEG and nocturnal secretion of growth hormone, cortisol and ACTH in patients with major depression].
    Frieboes RM; Schier T; Guldner J; Colla-Müller M; Murck H; Steiger A
    Wien Med Wochenschr; 1995; 145(17-18):499-500. PubMed ID: 8588384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.
    Alvarez-Castro P; Isidro ML; Garcia-Buela J; Leal-Cerro A; Broglio F; Tassone F; Ghigo E; Dieguez C; Casanueva FF; Cordido F
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):250-5. PubMed ID: 15272922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
    Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
    Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.